Report Detail
Global Biologics Drug Development Market Growth (Status and Outlook) 2019-2024
- RnM2815834 |
- 25 January, 2019 |
- Global |
- 119 Pages |
- LPI(LP Information) |
- Other
Biologics are defined as pharmaceutical products obtained from living cells or microorganisms.
According to this study, over the next five years the Biologics Drug Development market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Biologics Drug Development business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Biologics Drug Development market by product type, application, key companies and key regions.
This study considers the Biologics Drug Development value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Clinical Manufacturing
Formulation Development
Analytical Services
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
In-House
Outsource
Pharma Excess
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbvie
Allergan
Boehringer Ingelheim
Charles River Laboratories
Catalent
Lonza Group
Amgen
Sanofi
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Biologics Drug Development market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Biologics Drug Development market by identifying its various subsegments.
Focuses on the key global Biologics Drug Development players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biologics Drug Development with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Biologics Drug Development submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Biologics Drug Development Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Biologics Drug Development Market Size 2014-2024
- 2.1.2 Biologics Drug Development Market Size CAGR by Region
- 2.2 Biologics Drug Development Segment by Type
- 2.2.1 Clinical Manufacturing
- 2.2.2 Formulation Development
- 2.2.3 Bioassay Development
- 2.2.4 Analytical Services
- 2.3 Biologics Drug Development Market Size by Type
- 2.3.1 Global Biologics Drug Development Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Biologics Drug Development Market Size Growth Rate by Type (2014-2019)
- 2.4 Biologics Drug Development Segment by Application
- 2.4.1 In-House
- 2.4.2 Outsource
- 2.4.3 Pharma Excess
- 2.5 Biologics Drug Development Market Size by Application
- 2.5.1 Global Biologics Drug Development Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Biologics Drug Development Market Size Growth Rate by Application (2014-2019)
3 Global Biologics Drug Development by Players
- 3.1 Global Biologics Drug Development Market Size Market Share by Players
- 3.1.1 Global Biologics Drug Development Market Size by Players (2017-2019)
- 3.1.2 Global Biologics Drug Development Market Size Market Share by Players (2017-2019)
- 3.2 Global Biologics Drug Development Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Biologics Drug Development by Regions
- 4.1 Biologics Drug Development Market Size by Regions
- 4.2 Americas Biologics Drug Development Market Size Growth
- 4.3 APAC Biologics Drug Development Market Size Growth
- 4.4 Europe Biologics Drug Development Market Size Growth
- 4.5 Middle East & Africa Biologics Drug Development Market Size Growth
5 Americas
- 5.1 Americas Biologics Drug Development Market Size by Countries
- 5.2 Americas Biologics Drug Development Market Size by Type
- 5.3 Americas Biologics Drug Development Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Biologics Drug Development Market Size by Countries
- 6.2 APAC Biologics Drug Development Market Size by Type
- 6.3 APAC Biologics Drug Development Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Biologics Drug Development by Countries
- 7.2 Europe Biologics Drug Development Market Size by Type
- 7.3 Europe Biologics Drug Development Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Biologics Drug Development by Countries
- 8.2 Middle East & Africa Biologics Drug Development Market Size by Type
- 8.3 Middle East & Africa Biologics Drug Development Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Biologics Drug Development Market Forecast
- 10.1 Global Biologics Drug Development Market Size Forecast (2019-2024)
- 10.2 Global Biologics Drug Development Forecast by Regions
- 10.2.1 Global Biologics Drug Development Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Biologics Drug Development Forecast by Type
- 10.8 Global Biologics Drug Development Forecast by Application
11 Key Players Analysis
- 11.1 Abbvie
- 11.1.1 Company Details
- 11.1.2 Biologics Drug Development Product Offered
- 11.1.3 Abbvie Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Abbvie News
- 11.2 Allergan
- 11.2.1 Company Details
- 11.2.2 Biologics Drug Development Product Offered
- 11.2.3 Allergan Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Allergan News
- 11.3 Boehringer Ingelheim
- 11.3.1 Company Details
- 11.3.2 Biologics Drug Development Product Offered
- 11.3.3 Boehringer Ingelheim Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Boehringer Ingelheim News
- 11.4 Charles River Laboratories
- 11.4.1 Company Details
- 11.4.2 Biologics Drug Development Product Offered
- 11.4.3 Charles River Laboratories Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Charles River Laboratories News
- 11.5 Catalent
- 11.5.1 Company Details
- 11.5.2 Biologics Drug Development Product Offered
- 11.5.3 Catalent Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Catalent News
- 11.6 Lonza Group
- 11.6.1 Company Details
- 11.6.2 Biologics Drug Development Product Offered
- 11.6.3 Lonza Group Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Lonza Group News
- 11.7 Amgen
- 11.7.1 Company Details
- 11.7.2 Biologics Drug Development Product Offered
- 11.7.3 Amgen Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Amgen News
- 11.8 Sanofi
- 11.8.1 Company Details
- 11.8.2 Biologics Drug Development Product Offered
- 11.8.3 Sanofi Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Sanofi News
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Biologics Drug Development . Industry analysis & Market Report on Biologics Drug Development is a syndicated market report, published as Global Biologics Drug Development Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Biologics Drug Development market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
